ArticleFrontiers in medicine2022

Soluble Interleukin-2 Receptor Predicts Treatment Outcome in Patients With Autoimmune Tubulointerstitial Nephritis. A Preliminary Study.

Satoka Shiratori-Aso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.